Cargando…
Spontaneous and Engineered Large Animal Models of Neurofibromatosis Type 1
Animal models are crucial to understanding human disease biology and developing new therapies. By far the most common animal used to investigate prevailing questions about human disease is the mouse. Mouse models are powerful tools for research as their small size, limited lifespan, and defined gene...
Autores principales: | Osum, Sara H., Watson, Adrienne L., Largaespada, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920315/ https://www.ncbi.nlm.nih.gov/pubmed/33669386 http://dx.doi.org/10.3390/ijms22041954 |
Ejemplares similares
-
Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1
por: Osum, Sara H., et al.
Publicado: (2023) -
Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo
por: Osum, Sara H, et al.
Publicado: (2021) -
Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1
por: Isakson, Sara H., et al.
Publicado: (2018) -
New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors
por: Williams, Kyle B., et al.
Publicado: (2020) -
Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment
por: Miller, Andrew H., et al.
Publicado: (2022)